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West Nile Virus in 
Birds, Argentina
To the Editor: West Nile virus 
(WNV), genus Flavivirus, family 
Flaviviridae has been rapidly dispers-
ing through the Americas since its in-
troduction in 1999 in New York (1). 
By 2004, serologic studies detected 
WNV-speciﬁ  c antibodies in birds and 
horses from Canada to northern South 
America (2–4). The ﬁ   rst report of 
WNV activity in the Southern Cone of 
South America surfaced in April 2006, 
when 3 horses died in Argentina (5). 
However, established transmission 
foci in Argentina are unknown. We re-
port evidence for the introduction and 
establishment of WNV in Argentina as 
early as January 2005.
Serum samples from free-ranging 
birds were collected from 5 locations 
in Argentina and screened for generic 
ﬂ  avivirus antibodies by using a block-
ing ELISA with monoclonal antibody 
6B6C-1 (6). Positive serum specimens 
were further characterized by plaque- 
reduction neutralization test (PRNT). 
We identiﬁ  ed the etiologic agent re-
sponsible for the previous ﬂ  avivirus 
infection by using the following cri-
teria: 80% neutralization of reference 
virus (WNV NY99-4132 or an Argen-
tinean strain of St. Louis encephalitis 
virus [SLEV CbaAr4005]) in serum 
diluted at least 1:40 and 4-fold greater 
titer compared with the other virus. 
Overall, 474 (25.6%) of 1,845 
serum specimens from 117 bird spe-
cies collected from January to June 
2006 tested positive when using the 
blocking ELISA; 30% inhibition was 
the threshold for a positive test. SLEV 
infections were conﬁ  rmed in 105 birds 
by PRNT; WNV infections were con-
ﬁ  rmed in 43 birds. Anti-WNV anti-
body titers ranged from 40 to 2,560 
in birds collected as early as January 
2005 in Córdoba City and as late as 
June 2006 in Mar Chiquita (Table). 
Recent WNV activity was indicated 
by seroconversion in 3 banded rufous 
hornero in Córdoba City between 
January and March 2005. Although 
659 (1.5%) of serum samples were 
positive for SLEV, no WNV infec-
tion was detected in free-ranging birds 
collected in 2004. As early as January 
2005, WNV was detected in a sero-
conversion so we suspect WNV was 
introduced before 2005 at the end of 
2004 in all 5 sampling locations and in 
a variety of ecosystems: Córdoba, pe-
riurban (1.1%, 6/543); Mar Chiquita, 
thorn forest (5.1%, 16/313); Monte 
Alto, semidry chaco forest (9.8%, 
8/82); Montecristo, cropland (9.5%, 
2/21); and San Miguel de Tucumán, 
periurban yungas foothills (4.9%, 
12/227).
In 2006, WNV was isolated from 
equines in Buenos Aires province (5). 
WNV transmission to resident birds 
collected further north in Córdoba, 
Chaco, and Tucumán provinces was 
detected in 2005 and 2006. Our data 
suggest that WNV was introduced into 
Argentina before 2005 and maintained 
naturally in enzootic foci where nu-
merous bird species from many fami-
lies were exposed. Presumably, as in 
North America, locally abundant pas-
serine birds such as turdids (thrushes) 
are amplifying hosts. If common spe-
cies of the Furnariidae (a family ab-
sent from temperate North America) 
prove to be competent hosts, they 
could play an important role in WNV 
transmission in Argentina because 
of their frequent exposure to WNV. 
Twelve (12.5%) of 96 F. ruffus sam-
pled in 2005 and 2006 tested positive.
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How WNV reached Argentina may 
never be known. Dispersal by migrating 
birds is a popular hypothesis, although 
relatively few North American breeding 
birds migrate to Argentina, and austral 
migrants number fewer than boreal mi-
grants. Komar and Clark (2) suggested 
that bird species in the order Charadrii-
formes, such as shorebirds and terns, 
are candidates for carrying WNV from 
North America to South America due 
to long lasting high-level viremias, 
occasional persistent infectious viral 
loads in skin, and direct, long-distance 
ﬂ  ights. WNV spread southward from 
the United States to northern South 
America between 1999 and 2004 fol-
lowing a stepping stone pattern, con-
sistent with spread by birds. Moreover, 
introduction of WNV into Argentina by 
migratory birds could explain the pres-
ence of the virus in many places in a 
brief period. However, for migratory 
birds (211 serum samples tested) in this 
study, serologic test results were nega-
tive.
The high titers of WNV-reactive 
antibody are strongly indicative of 
WNV infections. Overall, 216 se-
rum specimens reacted by PRNT test 
against SLEV, WNV or both at titers 
>20. Sixty-eight serum samples remain 
unidentiﬁ  ed. The large number of un-
identiﬁ  ed  ﬂ  avivirus-positive  samples 
detected by PRNT, ELISA, or both 
(148/474) could be due to 1) false 
positives; 2) cross-reactions between 
WNV- and SLEV-reactive antibodies 
that prevented deﬁ  nitive diagnosis by 
PRNT; 3) cross-reactive antibody and 
multiple, heterologous ﬂ  avivirus infec-
tions; 4) previous infections by both 
WNV and SLEV; and/or 5) presence 
of other ﬂ  aviviruses circulating in Ar-
gentina. SLEV is endemic throughout 
Argentina and, like WNV, belongs to 
the Japanese encephalitis virus sero-
complex. Hemagglutination-inhibiting 
antibodies against several Brazilian ﬂ  a-
viviruses (e.g., Bussuquara, Ilheus, Ro-
cio viruses) have been reported in the 
neotropical region of extreme northern 
Argentina (7), but these viruses have 
not been isolated in Argentina. 
Our serologic data suggest that 
WNV has established itself in 4 eco-
logic regions in Argentina in a brief 
period. Additional studies are needed 
to deﬁ  ne the reservoir hosts and vec-
tors of WNV in Argentina, and most 
importantly, to deﬁ  ne the public health 
risk this virus represents.   
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Table. Prevalence of West Nile virus–neutralizing antibodies among birds grouped by taxonomic family, sampled in Chaco, Córdoba,
and Tucumán Provinces, Argentina, 2004–2006* 
Bird family  No. positive  No. tested  % Positive (95% CI)  Range of PRNT80 titer†
Cardinalidae 2 54 3.7 (1.0–12.5) 80–160
Columbidae   4 270 1.5 (0.6–3.8) 80–1,280
Dendrocolaptidae  4 17 23.5 (9.6–47.3) 320–2,560
Falconidae 3 5 60.0 (23.1–88.2) 320–2,560
Furnariidae   12 201 6.0 (3.4–10.1) 80–1,280
Icteridae 3 137 2.2 (0.7–6.2) 40–320
Passeridae 1 87 1.1 (0.2–6.2) 40
Phasianidae 2 8 25.0 (7.1–59.1) 320
Polioptilidae 2 7 28.6 (8.2–64.1) 80–640
Troglodytidae                     1 17 5.9 (1.0–27.0) 80
Turdidae 8 132 6.1 (3.1–11.5) 40–1,280
Tyrannidae 1 370 0.3 (0.05–1.5) 160
*Most of these families are of the order Passeriformes except for Falconidae (Falconiformes), Phasianidae (Galliformes), and Columbidae 
(Columbiformes). CI, confidence internal, determined by the Wilson score method for binomial proportions, without continuity correction. 
†PRNT, plaque-reduction neutralization test. Titers are expressed as inverse of dilution. LETTERS
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Clostridium 
difﬁ  cile Surveillance 
Trends, Saxony, 
Germany
To the Editor: Vonberg et al. (1) 
recently commented on the increase of 
Clostridium difﬁ  cile seen in US hos-
pitals by using discharge diagnoses 
and conﬁ   rmed the observation from 
the United States (2) with hospital 
discharge data from Germany during 
2000 through 2004. C. difﬁ  cile ribo-
type 027 has recently been isolated in 
Germany (3). We further contribute 
to the assessment of C. difﬁ  cile as an 
emerging threat by looking at popula-
tion surveillance data.
C. difﬁ  cile is not a federal notiﬁ  -
able disease in Germany, which limits 
our ability to analyze national sur-
veillance trends. However, in 2002 
the state of Saxony implemented ad-
ditional mandatory surveillance of 
community- and hospital-acquired 
infectious enteritis caused by labora-
tory-conﬁ  rmed C. difﬁ  cile.
To check for an increase in noti-
ﬁ  cations due to reporting bias of gas-
troenteric diseases, we compared the 
quarterly incidence data from 2002 
through 2006 with data on Salmonella 
spp. infections (usually reported by lo-
cal general practitioners) and rotavirus 
and norovirus infections (both usually 
reported by clinics). The potential 
problem of reporting bias for gastro-
enteric diseases has been addressed re-
cently (4). Information about age and 
sex of C. difﬁ  cile patients was avail-
able for 2006 only.
Quarterly incidences for C. dif-
ﬁ  cile in Saxony were from 1.7–3.8 per 
100,000 population in 2002 and 2003 
and continued to increase to 14.8 cases 
per 100,000 population in 2006 (Fig-
ure). This constitutes a 6-fold increase 
of the yearly average of C. difﬁ  cile in-
cidence rates between 2002 and 2006. 
The third quarter of 2005 experienced a 
sharp drop that could not be explained 
retrospectively and might have resulted 
from transition to new procedures for 
data collection and management.
Gastroenteric infections showed 
clear seasonality with a slightly de-
creasing yearly trend for Salmonella 
spp. and seasonal values from 13.8 
cases per 100,000 in winter to summer 
peaks of 56.8. Rotavirus infections 
displayed an even stronger seasonal-
ity, with values from 7.0 cases per 
100,000 in summer to winter peaks 
of 140.3. Norovirus infections peaked 
again during winter, at 137.2 cases per 
100,000 but had as few as 11.0 cases 
per 100,000 during summer. Notiﬁ  ca-
tion does not suggest reporting bias of 
gastroenteric infections.
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Figure. Quarterly incidence per 100,000 population of Clostridium difﬁ  cile infections 
compared with gastroenteric infections caused by Salmonella spp., rotaviruses, and 
noroviruses in Saxony, Germany, 2002–2006. Note the log scale on the y axis.